Tue. 12 Mar 2024, 7:51am ET
Benzinga
Earnings, News
Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.02 by 250 percent. This is a 450 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $135.42 million which beat the analyst consensus estimate of $123.96 million by 9.25 percent. This is a 7.62 percent increase over sales of $125.83 million the same period last year.